313,170 Shares in Select Medical Holdings Co. (NYSE:SEM) Bought by Empowered Funds LLC

Empowered Funds LLC acquired a new stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 313,170 shares of the health services provider's stock, valued at approximately $5,903,000. Empowered Funds LLC owned approximately 0.24% of Select Medical at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its holdings in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock worth $81,000 after buying an additional 330 shares in the last quarter. KBC Group NV increased its holdings in Select Medical by 4.5% in the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider's stock worth $455,000 after purchasing an additional 563 shares in the last quarter. Swiss National Bank increased its holdings in Select Medical by 0.4% in the 3rd quarter. Swiss National Bank now owns 215,900 shares of the health services provider's stock worth $7,528,000 after purchasing an additional 800 shares in the last quarter. Quarry LP acquired a new position in Select Medical in the 3rd quarter worth about $30,000. Finally, Sippican Capital Advisors increased its holdings in Select Medical by 7.3% in the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock worth $252,000 after purchasing an additional 912 shares in the last quarter. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Trading Down 0.9 %

Shares of Select Medical stock traded down $0.17 on Friday, hitting $18.58. 492,206 shares of the company's stock traded hands, compared to its average volume of 706,992. Select Medical Holdings Co. has a one year low of $18.02 and a one year high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company has a fifty day moving average of $19.19 and a two-hundred day moving average of $28.53. The company has a market capitalization of $2.41 billion, a price-to-earnings ratio of 8.68, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45.

Insider Activity at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the company's stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the company's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SEM. StockNews.com cut Select Medical from a "buy" rating to a "hold" rating in a report on Thursday. Benchmark cut Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. UBS Group lowered their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, January 3rd. Finally, Royal Bank of Canada upped their price target on Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Select Medical has a consensus rating of "Hold" and an average price target of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.